Nicole Sandford - 28 Oct 2024 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: AWHL
Reported as of: 28 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Oct 2024, 18:47:01 UTC
Prior SEC filing: 09 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Nicole Sandford

Key filing fact

Nicole Sandford filed Form 4 for Aspira Women's Health Inc. (AWHL) on 28 Oct 2024.

Key facts

This page summarizes Nicole Sandford's Form 4 filing for Aspira Women's Health Inc. (AWHL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Oct 2024, 18:47.

Change

Previous filing in this sequence was filed on 09 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AWH transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 28 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

In accordance with her amended contract effective September 1, 2024, the award will vest 100% on December 31, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.